Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Biomedical Optics|June 17, 2017
Optical imaging of radiation-induced metabolic changes in radiation-sensitive and resistant cancer cellsKinan Alhallak, Samir V Jenkins, David E Lee, et al.
Plos One|August 30, 2021
Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cellsIngrid Safina, Zeid A Nima Al Sudani, Ahmed Hashoosh, et al.
Biochemical and Biophysical Research Communications|June 28, 2005
Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant proteinRicardo J M G E Brandwijk, Irina Nesmelova, Ruud P M Dings, et al.
Bioconjugate Chemistry|December 22, 2009
Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulveneRuud P M Dings, Emily S Van Laar, Melissa Loren, et al.
The Biochemical Journal|April 24, 2003
Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptideRuud P M Dings, Monica M Arroyo, Nathan A Lockwood, et al.
Chemical Biology & Drug Design|June 27, 2026
Synthesis of Peptide Analogs From Fish Venom With Potential Antimicrobial and Anticancer ActivityRoberto de la Salud Bea, Qian Shen, Elaine Frawley, et al.
Investigational New Drugs|February 9, 2013
Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancerRuud P M Dings, Joseph I Levine, Susan G Brown, et al.
International Journal of Radiation Biology|December 18, 2018
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in miceGunnar Boysen, Azemat Jamshidi-Parsian, Mary A Davis, et al.
Cell Reports. Medicine|March 11, 2026
Detection of mitochondrial DNA mutations in T cells following 5-FU or cisplatin exposureCatherine Kirkpatrick, Charles M Quick, Steven R Post, et al.
Cancer Letters|April 2, 2008
Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulvenRuud P M Dings, Emily S Van Laar, Jeremy Webber, et al.
Pageof 7